Human T-cell lymphotropic virus type 1 (HTLV-1) infected cells identified by flow cytometry and HTLV-1 proviral load

2015 ◽  
Vol 72 (5) ◽  
pp. AB160
2011 ◽  
Vol 8 (1) ◽  
pp. 535 ◽  
Author(s):  
Walter K Neto ◽  
Antonio C Da-Costa ◽  
Ana Carolina S de Oliveira ◽  
Vanessa P Martinez ◽  
Youko Nukui ◽  
...  

2017 ◽  
Vol 55 (9) ◽  
pp. 2838-2849 ◽  
Author(s):  
Madoka Kuramitsu ◽  
Tsuyoshi Sekizuka ◽  
Tadanori Yamochi ◽  
Sanaz Firouzi ◽  
Tomoo Sato ◽  
...  

ABSTRACTWestern blotting (WB) for human T cell leukemia virus type 1 (HTLV-1) is performed to confirm anti-HTLV-1 antibodies detected at the initial screening of blood donors and in pregnant women. However, the frequent occurrence of indeterminate results is a problem with this test. We therefore assessed the cause of indeterminate WB results by analyzing HTLV-1 provirus genomic sequences. A quantitative PCR assay measuring HTLV-1 provirus in WB-indeterminate samples revealed that the median proviral load was approximately 100-fold lower than that of WB-positive samples (0.01 versus 0.71 copy/100 cells). Phylogenic analysis of the complete HTLV-1 genomes of WB-indeterminate samples did not identify any specific phylogenetic groups. When we analyzed the nucleotide changes in 19 HTLV-1 isolates from WB-indeterminate samples, we identified 135 single nucleotide substitutions, composed of four types, G to A (29%), C to T (19%), T to C (19%), and A to G (16%). In the most frequent G-to-A substitution, 64% occurred at GG dinucleotides, indicating that APOBEC3G is responsible for mutagenesis in WB-indeterminate samples. Moreover, interestingly, five WB-indeterminate isolates had nonsense mutations in Pol and/or Tax, Env, p12, and p30. These findings suggest that WB-indeterminate carriers have low production of viral antigens because of a combination of a low proviral load and mutations in the provirus, which may interfere with host recognition of HTLV-1 antigens.


Author(s):  
Raonne Souza Almeida Alves Menezes ◽  
Bernardo Galvão Castro Filho ◽  
Maria Fernanda Rios Grassi

This study aimed to describe comorbidities and symptoms of asymptomatic HTLV-1-infected patients according to the proviral load. Medical records were revised and patients categorized in high and low proviral load groups: >5% and <5% -infected cells, respectively. Frequency of symptoms was quantified. A total of 64 patients were evaluated. Twenty three (36%) patients had high proviral load. All patients had clinical abnormalities reported in the medical records. The most frequently comorbidities were hypertension (37.5%) and depression (25%) and the most frequent symptoms were neurological (82.8%) and ophthalmologic (65.6%). There were no differences in the frequencies of clinical manifestations in patients with low and high proviral load, except for urinary retention, that was more prevalent in the group with high proviral (34.8%). In summary, patients infected with HTLV-1 asymptomatic have a wide spectrum of clinical abnormalities and should be closely followed in order to identify the development of HTLV-1-associated diseases.


2017 ◽  
Vol 372 (1732) ◽  
pp. 20160272 ◽  
Author(s):  
Charles R. M. Bangham ◽  
Masao Matsuoka

Human T-cell leukaemia virus type 1 (HTLV-1) causes not only adult T-cell leukaemia-lymphoma (ATL), but also inflammatory diseases including HTLV-1-associated myelopathy/tropical spastic paraparesis. HTLV-1 transmits primarily through cell-to-cell contact, and generates abundant infected cells in the host in order to survive and transmit to a new host. The resulting high proviral load is closely associated with the development of ATL and inflammatory diseases. To increase the number of infected cells, HTLV-1 changes the immunophenotype of infected cells, induces proliferation and inhibits apoptosis through the cooperative actions of two viral genes, tax and HTLV-1 bZIP factor ( HBZ ). As a result, infected cells survive, proliferate and infiltrate into the tissues, which is critical for transmission of the virus. Thus, the strategy of this virus is indivisibly linked with its pathogenesis, providing a clue for prevention and treatment of HTLV-1-induced diseases. This article is part of the themed issue ‘Human oncogenic viruses’.


2011 ◽  
Vol 52 (3) ◽  
pp. 177-180 ◽  
Author(s):  
Cristina Castro-Lima Vargens ◽  
Maria Fernanda Rios Grassi ◽  
Ney Boa-Sorte ◽  
Regina Helena Rathsam-Pinheiro ◽  
Viviana Nilla Olavarria ◽  
...  

1998 ◽  
Vol 75 (2) ◽  
pp. 123-140 ◽  
Author(s):  
Björn Albrecht ◽  
Nathaniel D. Collins ◽  
Garret C. Newbound ◽  
Lee Ratner ◽  
Michael D. Lairmore

Viruses ◽  
2015 ◽  
Vol 7 (11) ◽  
pp. 5643-5658 ◽  
Author(s):  
Camila Cánepa ◽  
Jimena Salido ◽  
Matías Ruggieri ◽  
Sindy Fraile ◽  
Gabriela Pataccini ◽  
...  

2019 ◽  
Vol 23 (2) ◽  
pp. 95-101 ◽  
Author(s):  
Regina Helena Rathsam-Pinheiro ◽  
Ney Boa-Sorte ◽  
Maria Fernanda Rios Grassi ◽  
Úrsula Cury Copello ◽  
Karla Tayrine Silva Guimarães Rios ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document